InvestorsHub Logo
Followers 43
Posts 4885
Boards Moderated 0
Alias Born 04/30/2005

Re: Joseph_K post# 427333

Monday, 08/14/2023 4:18:46 PM

Monday, August 14, 2023 4:18:46 PM

Post# of 462040
Serepta's gene therapy costs $3.2 Million per patient...so I'm wondering what Tasha is going to charge?

Going to be hard to compete with A2-73...even at the initial cost of $500k/year.

You have to have a market that will pay for your drug before you can make any money...and there's not too many people that can afford $3.2 Million for treatment!

Some of the issues highlighted in the article below.

https://www.investors.com/news/technology/srpt-stock-halted-sarepta-wins-fda-approval-for-duchenne-gene-therapy/?src=A00220
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News